Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee (Bone Marrow Transplantation, (2021), 56, 4, (786-797), 10.1038/s41409-020-01199-1)

Akshay Sharma, Sherif M. Badawy, Elizabeth M. Suelzer, Hemant S. Murthy, Pinki Prasad, Hesham Eissa, Paul A. Carpenter, Mehdi Hamadani, Myriam Labopin, Hélène Schoemans, André Tichelli, Rachel Phelan, Betty K. Hamilton, David Buchbinder, Annie Im, Rebecca Hunter, Ruta Brazauskas, Linda J. Burns*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

Unfortunately, the Funding information was incorrect. The correct Funding is given below. Funding: The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health supported this publication under Award Number K23HL150232 (SMB). AS is the recipient of an American Society of Scholar Award. The CIBMTR is supported primarily by Public Health Service U24CA076518 from the National Cancer Institute (NCI), the NHLBI, and the National Institute of Allergy and Infectious Diseases (NIAID); R21HL140314 and U01HL128568 from the NHLBI; HHSH250201700006C, SC1MC31881-01-00, and HHSH250201700007C from the Health Resources and Services Administration (HRSA); and N00014-18-1-2850, N00014-18-1-2888, and N00014-20-1-2705 from the Office of Naval Research; Additional federal support is provided by P01CA111412, R01CA152108, R01CA215134, R01CA218285, R01CA231141, R01AI128775, R01HL129472, R01HL130388, R01HL131731, U01AI069197, U01AI126612, and BARDA. The views expressed in this article do not reflect the official policy or position of the NIH, the Department of the Navy, the Department of Defense, HRSA, or any other agency of the United States Government. The original article has been corrected.

Original languageEnglish (US)
Pages (from-to)1486
Number of pages1
JournalBone Marrow Transplantation
Volume56
Issue number6
DOIs
StatePublished - Jun 2021

Funding

Funding: The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health supported this publication under Award Number K23HL150232 (SMB). AS is the recipient of an American Society of Scholar Award. The CIBMTR is supported primarily by Public Health Service U24CA076518 from the National Cancer Institute (NCI), the NHLBI, and the National Institute of Allergy and Infectious Diseases (NIAID); R21HL140314 and U01HL128568 from the NHLBI; HHSH250201700006C, SC1MC31881-01-00, and HHSH250201700007C from the Health Resources and Services Administration (HRSA); and N00014-18-1-2850, N00014-18-1-2888, and N00014-20-1-2705 from the Office of Naval Research; Additional federal support is provided by P01CA111412, R01CA152108, R01CA215134, R01CA218285, R01CA231141, R01AI128775, R01HL129472, R01HL130388, R01HL131731, U01AI069197, U01AI126612, and BARDA. The views expressed in this article do not reflect the official policy or position of the NIH, the Department of the Navy, the Department of Defense, HRSA, or any other agency of the United States Government. The original article has been corrected.

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Fingerprint

Dive into the research topics of 'Correction: Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee (Bone Marrow Transplantation, (2021), 56, 4, (786-797), 10.1038/s41409-020-01199-1)'. Together they form a unique fingerprint.

Cite this